Hong Luo
- Oncology top 2%
- Molecular Biology top 10%
- Neurology top 1%
- Immunology top 5%
- Infectious Diseases top 2%
- Topics
- Cystic Fibrosis Research Advances (15 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers)CAR-T cell therapy research (14 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaThe Journal of Immunology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hong Luo
157 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 1.2k
- Molecular Biology 1.1k
- Neurology 803
- Immunology 790
- Infectious Diseases 675
Countries citing papers authored by Hong Luo
This map shows the geographic impact of Hong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Luo more than expected).
Fields of papers citing papers by Hong Luo
This network shows the impact of papers produced by Hong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Luo. The network helps show where Hong Luo may publish in the future.
Co-authorship network of co-authors of Hong Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Hong Luo. A scholar is included among the top collaborators of Hong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Luo. Hong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 46 | |
| 7 | Characteristics and Follow-Up of Organizing Pneumonia Associated with Haematological Malignancies | 1 |
| 8 | 23 | |
| 9 | 1 | |
| 10 | 12 | |
| 11 | 3 | |
| 12 | 36 | |
| 13 | 8 | |
| 14 | 21 | |
| 15 | 129 | |
| 16 | USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer | 4 |
| 17 | 70 | |
| 18 | 11 | |
| 19 | 6 | |
| 20 | Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities | 3 |
About Hong Luo
Hong Luo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 172 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Neurology (803 citations), Critical Care and Intensive Care Medicine (262 citations) and Oncology (1.2k citations). Hong Luo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bizhi Shi, Zonghai Li, Hua Jiang, Ruixin Sun, Shengmeng Di, Xiuqi Wu, Yansha Sun, Junli Jia, Yumiao Zhao and Qin-Fu Xu. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.